Scalper1 News
Eli Lilly (LLY) stock jumped to a 10-year high above 75 on the stock market today after Morgan Stanley upgraded the stock to overweight from underweight. In afternoon trading, Lilly stock was near 73, up 2.5%. Analyst David Risinger raised his expectations for two potential blockbusters in the pipeline: cholesterol drug evacetrapib and Alzheimer’s disease treatment solanezumab. He only put 50% odds of success on both of their phase three trials, Scalper1 News
Scalper1 News